9th November 2020 •
comment
Evaluating the Burden-of-Disease Endpoint to Assess Vaccine Efficacy
by Edde Loeliger and Bob Small
26th October 2020 •
comment
CONSIDERATIONS FOR EVALUATION OF COVID19 VACCINES
by World Health Organization
30th September 2020 •
comment
Considerations for Inclusion of Risk Populations into COVID-19 Vaccine Efficacy Trials
by Paul Oloo & Edde Loeliger
17th July 2020 •
comment
Core Elements for Advanced Stage Clinical Trials of COVID-19 Vaccine Candidates: Aspects to Consider
by Amol Chaudhari
26th June 2020 •
comment
Vaccine Efficacy Assessment for COVID-19
by Edde Loeliger and Bob Small
7th May 2020 •
comment